BlackRock’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6M | Sell |
10,858,900
-600,840
| -5% | -$1.64M | ﹤0.01% | 2757 |
|
|
2025
Q1 | $19.3M | Sell |
11,459,740
-473,336
| -4% | -$795K | ﹤0.01% | 2932 |
|
|
2024
Q4 | $19.5M | Buy |
11,933,076
+115,781
| +1% | +$189K | ﹤0.01% | 3027 |
|
|
2024
Q3 | $49.2M | Buy |
11,817,295
+771,847
| +7% | +$3.21M | ﹤0.01% | 2449 |
|
|
2024
Q2 | $60.3M | Buy |
11,045,448
+1,999,304
| +22% | +$10.9M | ﹤0.01% | 2280 |
|
|
2024
Q1 | $90.5M | Buy |
9,046,144
+576,922
| +7% | +$5.77M | ﹤0.01% | 2076 |
|
|
2023
Q4 | $34.6M | Buy |
8,469,222
+475,259
| +6% | +$1.94M | ﹤0.01% | 2665 |
|
|
2023
Q3 | $30.9M | Buy |
7,993,963
+109,186
| +1% | +$423K | ﹤0.01% | 2644 |
|
|
2023
Q2 | $47M | Buy |
7,884,777
+82,950
| +1% | +$494K | ﹤0.01% | 2476 |
|
|
2023
Q1 | $25.5M | Buy |
7,801,827
+16,476
| +0.2% | +$53.9K | ﹤0.01% | 2791 |
|
|
2022
Q4 | $30.8M | Buy |
7,785,351
+824,894
| +12% | +$3.26M | ﹤0.01% | 2746 |
|
|
2022
Q3 | $41.8M | Sell |
6,960,457
-34,872
| -0.5% | -$209K | ﹤0.01% | 2556 |
|
|
2022
Q2 | $45M | Buy |
6,995,329
+524,453
| +8% | +$3.37M | ﹤0.01% | 2530 |
|
|
2022
Q1 | $53.5M | Buy |
6,470,876
+500,173
| +8% | +$4.13M | ﹤0.01% | 2508 |
|
|
2021
Q4 | $92.4M | Buy |
5,970,703
+872,033
| +17% | +$13.5M | ﹤0.01% | 2245 |
|
|
2021
Q3 | $115M | Buy |
5,098,670
+3,283,779
| +181% | +$74M | ﹤0.01% | 2105 |
|
|
2021
Q2 | $35.7M | Buy |
1,814,891
+35,575
| +2% | +$699K | ﹤0.01% | 2881 |
|
|
2021
Q1 | $59.6M | Buy |
+1,779,316
| New | +$59.6M | ﹤0.01% | 2477 |
|